Loading…

Intracellular and plasma efavirenz concentrations in HIV-infected patients switching from successful protease inhibitor-based highly active antiretroviral therapy (HAART) to efavirenz-based HAART (SUSTIPHAR Study)

Objectives: To assess intracellular and plasma efavirenz concentrations in HIV-infected patients who switched to efavirenz-based highly active antiretroviral therapy (HAART) from successful protease inhibitor-based HAART. Patients and methods: A total of 49 patients were included in this observation...

Full description

Saved in:
Bibliographic Details
Published in:Journal of antimicrobial chemotherapy 2006-11, Vol.58 (5), p.1090-1093
Main Authors: Djabarouti, Sarah, Breilh, Dominique, Pellegrin, Isabelle, Lavit, Michel, Camou, Fabrice, Caubet, Olivier, Fleury, Hervé, Saux, Marie-Claude, Pellegrin, Jean-Luc
Format: Article
Language:English
Subjects:
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Objectives: To assess intracellular and plasma efavirenz concentrations in HIV-infected patients who switched to efavirenz-based highly active antiretroviral therapy (HAART) from successful protease inhibitor-based HAART. Patients and methods: A total of 49 patients were included in this observational cohort study. At inclusion, all patients had plasma HIV-RNA levels
ISSN:0305-7453
1460-2091
DOI:10.1093/jac/dkl348